452 related articles for article (PubMed ID: 24819917)
21. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
Benedict RH; Hulst HE; Bergsland N; Schoonheim MM; Dwyer MG; Weinstock-Guttman B; Geurts JJ; Zivadinov R
Mult Scler; 2013 Oct; 19(11):1478-84. PubMed ID: 23459570
[TBL] [Abstract][Full Text] [Related]
22. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
[TBL] [Abstract][Full Text] [Related]
23. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome.
Diker S; Has AC; Kurne A; Göçmen R; Oğuz KK; Karabudak R
Mult Scler Relat Disord; 2016 Nov; 10():14-21. PubMed ID: 27919482
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis].
Aldrete Cortez VR; Duriez-Sotelo E; Carrillo-Mora P; Pérez-Zuno JA
Neurologia; 2013 Sep; 28(7):394-9. PubMed ID: 23260448
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Khalil M; Enzinger C; Langkammer C; Tscherner M; Wallner-Blazek M; Jehna M; Ropele S; Fuchs S; Fazekas F
Mult Scler; 2009 Sep; 15(9):1048-54. PubMed ID: 19556316
[TBL] [Abstract][Full Text] [Related]
26. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
27. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
[TBL] [Abstract][Full Text] [Related]
28. Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis.
Hynčicová E; Vyhnálek M; Kalina A; Martinkovič L; Nikolai T; Lisý J; Hort J; Meluzínová E; Laczó J
J Neurol; 2017 Mar; 264(3):482-493. PubMed ID: 28028623
[TBL] [Abstract][Full Text] [Related]
29. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
[TBL] [Abstract][Full Text] [Related]
30. Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner.
Geisseler O; Pflugshaupt T; Bezzola L; Reuter K; Weller D; Schuknecht B; Brugger P; Linnebank M
Neuroimage Clin; 2016; 10():89-95. PubMed ID: 26759784
[TBL] [Abstract][Full Text] [Related]
31. Cognitive impairment among different clinical courses of multiple sclerosis.
Brissart H; Morele E; Baumann C; Perf ML; Leininger M; Taillemite L; Dillier C; Pittion S; Spitz E; Debouverie M
Neurol Res; 2013 Oct; 35(8):867-72. PubMed ID: 23816638
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
Neuroimage; 2006 Apr; 30(3):891-8. PubMed ID: 16360321
[TBL] [Abstract][Full Text] [Related]
33. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Debernard L; Melzer TR; Alla S; Eagle J; Van Stockum S; Graham C; Osborne JR; Dalrymple-Alford JC; Miller DH; Mason DF
Psychiatry Res; 2015 Dec; 234(3):352-61. PubMed ID: 26602610
[TBL] [Abstract][Full Text] [Related]
34. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis.
Yu CS; Lin FC; Liu Y; Duan Y; Lei H; Li KC
Eur J Radiol; 2008 Nov; 68(2):328-34. PubMed ID: 17928182
[TBL] [Abstract][Full Text] [Related]
35. Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis.
Bisecco A; Capuano R; Caiazzo G; d'Ambrosio A; Docimo R; Cirillo M; Russo A; Altieri M; Bonavita S; Rocca MA; Filippi M; Tedeschi G; Gallo A
Mult Scler; 2021 Jan; 27(1):134-138. PubMed ID: 31793399
[TBL] [Abstract][Full Text] [Related]
36. Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis.
Joly H; Capet N; Mondot L; Cohen M; Suply C; Bresch S; Lebrun-Frenay C
Mult Scler Relat Disord; 2020 Sep; 44():102374. PubMed ID: 32652509
[TBL] [Abstract][Full Text] [Related]
37. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
Rovaris M; Iannucci G; Falautano M; Possa F; Martinelli V; Comi G; Filippi M
J Neurol Sci; 2002 Mar; 195(2):103-9. PubMed ID: 11897239
[TBL] [Abstract][Full Text] [Related]
38. Subcortical atrophy and cognition: sex effects in multiple sclerosis.
Schoonheim MM; Popescu V; Rueda Lopes FC; Wiebenga OT; Vrenken H; Douw L; Polman CH; Geurts JJ; Barkhof F
Neurology; 2012 Oct; 79(17):1754-61. PubMed ID: 23019265
[TBL] [Abstract][Full Text] [Related]
39. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
[TBL] [Abstract][Full Text] [Related]
40. No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
Damasceno A; Damasceno BP; Cendes F
Mult Scler; 2016 Jan; 22(1):64-72. PubMed ID: 26432855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
